DNA methylation of ITGB2 contributes to allopurinol hypersensitivity
Clinical Immunology · 2023
DOI: 10.1016/j.clim.2023.109250 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Immunology, 2023. Verfasst von Yu Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Stevens-Johnson Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Chinese Academy of Meteorological Sciences, Natural Science Foundation of Hunan Province, Chiayi Chang Gung Memorial Hospital.
Abstract (Originalsprache)
BACKGROUNDS: HLA-B*58:01 allele was strongly associated with allopurinol induced severe cutaneous adverse drug reaction (SCAR). However, HLA-B genotype is not sufficient to predict the occurrence of allopurinol-induced SCAR. OBJECTIVE: To discover DNA methylation markers for allopurinol-induced SCAR which may improve the prediction accuracy of genetic testing. STUDY DESIGN: The study was designed as a retrospective case-control clinical study in multicenter hospitals across Taiwan, Mainland China, Malaysia and Canada. 125 cases of allopurinol-induced SCAR patients and 139 cases of allopurinol tolerant controls were enrolled in this study during 2005 to 2021. RESULTS: The results of genome-wide DNA methylation assay of 62 patients revealed that ITGB2 showed strong discriminative ability of allopurinol-induced SCAR in both HLA-B*58:01 positive and negative patients with AUC value of 0.9364 (95% CI 0.8682-1.000). In validation study, significant hypermethylation of ITGB2 were further validated in allopurinol-induced SCAR patients compared to tolerant controls, especially in those without HLA-B*58:01(AUC value of 0.8814 (95% CI 0.7121-1.000)). Additionally, the methylation levels of 2 sites on ITGB2 were associated with SCAR phenotypes. Combination of HLA-B*58:01 genotyping and ITGB2 methylation status could improve the prediction accuracy of allopurinol-induced SCAR with the AUC value up to 0.9387 (95% CI 0.9089-0.9684), while the AUC value of HLA-B*58:01 genotyping alone was 0.8557 (95% CI 0.8030-0.9083). CONCLUSIONS: Our study uncovers differentially methylated genes between allopurinol-induced SCAR patients and tolerant controls with positive or negative HLA-B*58:01 allele and provides the novel epigenetic marker that improves the prediction accuracy of genetic testing for prevention of allopurinol-induced SCAR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei and Keelung, Taiwan China; Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung M…
- College of Medicine, Chang Gung University, Taoyuan, Taiwan China; Division of Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan China.
- College of Medicine, Chang Gung University, Taoyuan, Taiwan China; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Chang Gung Memorial Hospital, Keelung and Linkou, Taiwan China.
- Hospital Sultanah Aminah, Clinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Malaysia.
- Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; British Columbia Children's Hospital Research Institute, Vancou…
Förderung
- Chinese Academy of Meteorological Sciences
- Natural Science Foundation of Hunan Province
- Chiayi Chang Gung Memorial Hospital
- CAMS Innovation Fund for Medical Sciences
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Liu, Y., Wang, C. W., Chen, C. B., Yu, K. H., Wu, Y. J., Choon, S. E., Chang, W. C., Yang, F., Luo, X. Q., Chung, W. H., Zhao, M., & Lu, Q. J. (2023). DNA methylation of ITGB2 contributes to allopurinol hypersensitivity. Clinical Immunology. https://doi.org/10.1016/j.clim.2023.109250
Vancouver
Liu Y, Wang CW, Chen CB, Yu KH, Wu YJ, Choon SE, et al. DNA methylation of ITGB2 contributes to allopurinol hypersensitivity. Clinical Immunology. 2023. doi:10.1016/j.clim.2023.109250
BibTeX
@article{Liu2023,
author = {Liu, Yu and Wang, Chuang-Wei and Chen, Chun-Bing and Yu, Kuang-Hui and Wu, Yeong-Jian and Choon, Siew-Eng and Chang, Wan-Chun and Yang, Fanping and Luo, Xiao-Qun and Chung, Wen-Hung and Zhao, Ming and Lu, Qian-Jin},
title = {DNA methylation of ITGB2 contributes to allopurinol hypersensitivity},
journal = {Clinical Immunology},
year = {2023},
doi = {10.1016/j.clim.2023.109250}
}
EUVIMED